LENALIDOMIDE for B-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,474 adverse event reports in the FDA FAERS database where LENALIDOMIDE was used for B-cell lymphoma.
Most Reported Side Effects for LENALIDOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 27,576 | 7.9% | 545 | 4,623 |
| Fatigue | 22,956 | 6.6% | 444 | 2,907 |
| Death | 19,213 | 5.5% | 19,190 | 1,415 |
| Off label use | 17,017 | 4.9% | 1,252 | 3,116 |
| Rash | 15,794 | 4.5% | 315 | 1,830 |
| Pneumonia | 14,807 | 4.2% | 1,646 | 11,418 |
| Plasma cell myeloma | 14,191 | 4.1% | 5,427 | 2,477 |
| Neuropathy peripheral | 10,215 | 2.9% | 210 | 988 |
| White blood cell count decreased | 9,996 | 2.9% | 176 | 1,895 |
| Constipation | 9,635 | 2.8% | 183 | 1,395 |
| Nausea | 9,206 | 2.6% | 250 | 1,848 |
| Asthenia | 8,192 | 2.3% | 424 | 2,679 |
| Product dose omission issue | 8,145 | 2.3% | 24 | 691 |
| Platelet count decreased | 7,491 | 2.1% | 397 | 1,855 |
| Neutropenia | 6,909 | 2.0% | 670 | 1,451 |
Other Indications for LENALIDOMIDE
Plasma cell myeloma (273,951)
Product used for unknown indication (20,069)
Myelodysplastic syndrome (14,132)
Diffuse large b-cell lymphoma (7,858)
Off label use (5,767)
Plasma cell myeloma in remission (4,678)
Follicular lymphoma (3,611)
Mantle cell lymphoma (2,989)
Non-hodgkin's lymphoma (2,744)
Plasma cell myeloma recurrent (2,451)
Other Drugs Used for B-cell lymphoma
RITUXIMAB (7,811)
CYCLOPHOSPHAMIDE (4,766)
VINCRISTINE (4,346)
DOXORUBICIN (3,947)
PREDNISONE (2,561)
BENDAMUSTINE (1,668)
PREDNISOLONE (1,489)
ETOPOSIDE (1,268)
IDELALISIB (1,240)
OBINUTUZUMAB (1,200)